A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohns Disease Intervention: Drug: Guselkumab Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials